Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
Exagen Inc. (Nasdaq: XGN), a leading autoimmune testing solutions provider, has announced its participation in the 2024 Cantor Global Healthcare Conference. The event is scheduled for September 17-19, 2024, at the InterContinental Barclay Hotel in New York City.
Key highlights:
- John Aballi, President and CEO, and Jeff Black, CFO, will represent Exagen
- They will participate in a fireside chat on Wednesday, September 18th, at 9:45 AM ET
- The conference provides a platform for healthcare companies to showcase their innovations and connect with investors
This participation underscores Exagen's commitment to engaging with the investment community and sharing insights into its autoimmune testing solutions.
Exagen Inc. (Nasdaq: XGN), un fornitore leader di soluzioni per il test autoimmune, ha annunciato la sua partecipazione alla 2024 Cantor Global Healthcare Conference. L'evento è in programma dal 17 al 19 settembre 2024, presso l'InterContinental Barclay Hotel di New York City.
Principali punti salienti:
- John Aballi, Presidente e CEO, e Jeff Black, CFO, rappresenteranno Exagen
- Partecipano a una conversazione informale il mercoledì 18 settembre, alle 9:45 AM ET
- La conferenza offre una piattaforma per le aziende sanitarie per mostrare le loro innovazioni e connettersi con gli investitori
Questa partecipazione sottolinea l'impegno di Exagen a interagire con la comunità degli investimenti e a condividere intuizioni sulle sue soluzioni di testing autoimmune.
Exagen Inc. (Nasdaq: XGN), un proveedor líder de soluciones de pruebas autoinmunitarias, ha anunciado su participación en la 2024 Cantor Global Healthcare Conference. El evento está programado del 17 al 19 de septiembre de 2024, en el InterContinental Barclay Hotel en Nueva York.
Puntos clave:
- John Aballi, Presidente y CEO, y Jeff Black, CFO, representarán a Exagen
- Participarán en un chat informal el miércoles 18 de septiembre, a las 9:45 AM ET
- La conferencia ofrece una plataforma para que las empresas de atención médica muestren sus innovaciones y se conecten con inversores
Esta participación subraya el compromiso de Exagen de interactuar con la comunidad de inversores y compartir conocimientos sobre sus soluciones de pruebas autoinmunitarias.
Exagen Inc. (Nasdaq: XGN), 오토면역 검사 솔루션의 선도적인 제공업체가 2024 Cantor Global Healthcare Conference에 참여한다고 발표했습니다. 이 행사는 2024년 9월 17일부터 19일까지 뉴욕시의 인터컨티넨탈 바클레이 호텔에서 열립니다.
주요 하이라이트:
- 존 아발리(John Aballi) 사장 겸 CEO와 제프 블랙(Jeff Black) CFO가 Exagen을 대표합니다.
- 그들은 9월 18일 수요일 오전 9시 45분 ET에 진행되는 파이어사이드 챗에 참여할 것입니다.
- 이 회의는 의료 기업들이 그들의 혁신을 선보이고 투자자들과 연결할 수 있는 플랫폼을 제공합니다.
이번 참여는 Exagen이 투자 커뮤니티와 소통하고 자사의 오토면역 검사 솔루션에 대한 통찰력을 공유하겠다는 의지를 강조합니다.
Exagen Inc. (Nasdaq: XGN), un fournisseur leader de solutions de tests auto-immuns, a annoncé sa participation à la 2024 Cantor Global Healthcare Conference. L'événement est prévu du 17 au 19 septembre 2024 à l'InterContinental Barclay Hotel à New York.
Points clés :
- John Aballi, Président et PDG, et Jeff Black, CFO, représenteront Exagen
- Ils participeront à une discussion informelle le mercredi 18 septembre à 9h45 ET
- La conférence offre une plateforme aux entreprises de la santé pour présenter leurs innovations et se connecter avec des investisseurs
Cette participation souligne l'engagement d'Exagen à interagir avec la communauté d'investissement et à partager des informations sur ses solutions de tests auto-immuns.
Exagen Inc. (Nasdaq: XGN), ein führender Anbieter von Lösungen für autoimmune Tests, hat seine Teilnahme an der 2024 Cantor Global Healthcare Conference bekannt gegeben. Die Veranstaltung findet vom 17. bis 19. September 2024 im InterContinental Barclay Hotel in New York City statt.
Wichtige Highlights:
- John Aballi, Präsident und CEO, und Jeff Black, CFO, werden Exagen vertreten
- Sie nehmen an einem informellen Gespräch am Mittwoch, den 18. September, um 9:45 Uhr ET teil
- Die Konferenz bietet eine Plattform für Gesundheitsunternehmen, um ihre Innovationen zu präsentieren und sich mit Investoren zu vernetzen
Diese Teilnahme unterstreicht das Engagement von Exagen, mit der Investitionsgemeinschaft in Kontakt zu treten und Einblicke in seine Lösungen für autoimmune Tests zu teilen.
- None.
- None.
CARLSBAD, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the 2024 Cantor Global Healthcare Conference, which takes place September 17-19, 2024, at the InterContinental Barclay Hotel in New York City. John Aballi, Exagen’s President and Chief Executive Officer and Jeff Black, Exagen’s Chief Financial Officer, will participate in a fireside chat on Wednesday, September 18th, at 9:45 AM ET.
About Exagen Inc.
Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of improving patients’ clinical outcomes. Exagen is located in San Diego County, California.
For more information, please visit Exagen.com or follow @ExagenInc on X (formerly known as Twitter).
Contact:
Ryan Douglas
Exagen Inc.
ir@exagen.com
760.560.1525
FAQ
When is Exagen Inc. (XGN) participating in the 2024 Cantor Global Healthcare Conference?
Who will represent Exagen Inc. (XGN) at the 2024 Cantor Global Healthcare Conference?
Where is the 2024 Cantor Global Healthcare Conference being held?
What type of event will Exagen Inc. (XGN) participate in at the conference?
What is Exagen Inc. (XGN) known for in the healthcare industry?
